Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
51.81B
Market cap51.81B
Price-Earnings ratio
53.28
Price-Earnings ratio53.28
Dividend yield
Dividend yield
Average volume
2.67M
Average volume2.67M
High today
$90.21
High today$90.21
Low today
$88.40
Low today$88.40
Open price
$90.21
Open price$90.21
Volume
2.62M
Volume2.62M
52 Week high
$96.29
52 Week high$96.29
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

As of today, Edwards Lifesciences(EW) shares are valued at $89.90. The company's market cap stands at 51.81B, with a P/E ratio of 53.28.

On 2026-09-05, Edwards Lifesciences(EW) stock traded between a low of $88.40 and a high of $90.21. Shares are currently priced at $89.90, which is +1.7% above the low and -0.3% below the high.

The Edwards Lifesciences(EW)'s current trading volume is 2.62M, compared to an average daily volume of 2.67M.

During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $96.29 at its peak.

During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $96.29 at its peak.

EW News

MarketWatch 2d
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch

...

Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 4d
Is Edwards Lifesciences Undervalued As TAVR And EVOQUE Growth Hopes Build?

Advertisement Recent share price performance and business snapshot Edwards Lifesciences (EW) stock has moved quietly higher, with the share price at US$90.75...

Is Edwards Lifesciences Undervalued As TAVR And EVOQUE Growth Hopes Build?
TipRanks 4d
Top Edwards Lifesciences Executive Makes Eye-Catching Stock Move

New insider activity at Edwards Lifesciences ( (EW) ) has taken place on August 31, 2026. Andrew M. Dahl, Senior Vice President and Corporate Controller at Edw...

Analyst ratings

79%

of 29 ratings
Buy
79.3%
Hold
20.7%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.